Item 5. Market for Registrant’s Common Equity
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY,
RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Market Information
The Company’s common stock trades on The Nasdaq
Capital Market under the symbol “DTST.”
Holders of the Company’s Common Stock
As of March 27, 2025, we had 31 shareholders of record
of the Company’s common stock, one of which was Cede & Co., a nominee for Depository Trust Company (“DTC”). All
the shares of the Company’s common stock held by brokerage firms, banks and other financial institutions as nominees for beneficial
owners are deposited into participant accounts at DTC and are therefore considered to be held or recorded by Cede & Co. as one stockholder.
Dividend Policy
The Company has not declared or paid dividends on
common stock since its formation and does not anticipate paying dividends in the foreseeable future. The declaration or payment of dividends,
if any, in the future, will be at the discretion of DSC’s Board of Directors and will depend on the then- current financial condition,
results of operations, capital requirements and other factors deemed relevant by the Board. Each share of Series A Preferred Stock entitles
its holder to receive cash dividends at a rate of ten percent (10%) per annum on the original issue price, compounding annually, in preference
to holders of common stock. Preferred dividends are accrued quarterly. No shares of Series A Preferred Stock are outstanding, and no dividends
have been paid to date since May 2021 when all of the then outstanding shares of Series A Preferred Stock were converted into shares of
the Company’s common stock.
Recent Sales of Unregistered Securities
The Company did not sell any equity securities during
the three months ended, or the fiscal year ended, December 31, 2024, that were not registered under the Securities Act, other than as previously
disclosed in its filings with the Securities and Exchange Commission (the “SEC”).
Issuer Purchases of Equity Securities
There were no issuer purchases of equity securities
during the year ended, December 31, 2024.
Securities Authorized for Issuance Under Equity Compensation Plans
The following table contains information about the
Company’s equity compensation plans as of December 31, 2024:
29
Equity Compensation Plan Information
Number of
securities to be
issued upon
exercise of
outstanding
options and
warrants
Weighted-
average
exercise price of
outstanding
options,
warrants and
rights
Number of
securities
remaining
available for
future issuance
under equity
compensation
plans (excluding
securities
reflected in
column (a)
Plan Category
(a)
(b)
(c)
Equity compensation plans approved by security holders
2010 Plan
129,152
$
3.41
—
2021 Plan
466,195
$
2.25
479,653
Equity compensation plans not approved by stockholders
N/A
N/A
N/A
Total
595,347
$
2.48
479,65 3
ITEM 6. RESERVED